UnitedHealth Group Incorporated $UNH Position Reduced by Stock Yards Bank & Trust Co.

Stock Yards Bank & Trust Co. lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 75,996 shares of the healthcare conglomerate’s stock after selling 1,026 shares during the period. Stock Yards Bank & Trust Co.’s holdings in UnitedHealth Group were worth $23,709,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Bayforest Capital Ltd grew its holdings in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its position in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 50 shares during the last quarter. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group during the first quarter valued at about $42,000. Kentucky Trust Co raised its position in shares of UnitedHealth Group by 53.8% during the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock valued at $45,000 after buying an additional 50 shares during the last quarter. Finally, O Brien Wealth Partners LLC increased its stake in UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock valued at $46,000 after acquiring an additional 37 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have weighed in on the stock. Bank of America upped their price objective on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a research note on Monday, August 18th. Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Morgan Stanley increased their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. Finally, Sanford C. Bernstein raised their target price on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have given a Sell rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Hold” and a consensus target price of $358.95.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $360.17 on Friday. The firm has a 50 day moving average of $307.84 and a 200-day moving average of $355.58. The stock has a market capitalization of $326.20 billion, a PE ratio of 15.61, a PEG ratio of 2.30 and a beta of 0.47. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.